SLC12A3 and pseudohypoaldosteronism type 2: Overactivation of NCC, due to genetic mutations in upstream regulatory kinases or E3 ubiquitin ligases, is the basis of hypertension in patients with Gordon syndrome (pseudohypoaldosteronism type II, PHAII) (Hadchouel et al., 2016).